JYOTHI PRASAD; Ramanadham

Patent Applications and Registrations

Patent applications and USPTO patent grants for JYOTHI PRASAD; Ramanadham.The latest application filed is for "6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors".

Company Profile

1.11.11

JYOTHI PRASAD; Ramanadham - Hyderabad IN
JYOTHI PRASAD; Ramanadham - Banjara Hills IN
Jyothi Prasad; Ramanadham - Andhra Pradesh IN
Jyothi Prasad; Ramanadham - Hyderbad IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors App 20190201408 - ADIBHATLA KALI SATYA; Bhujanga rao ; et al.	2019-07-04
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors App 20170079983 - ADIBHATLA KALI SATYA; Bhujanga rao ; et al.	2017-03-23
6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors Grant 9,481,655 - Adibhatla Kali Satya , et al. November 1, 2	2016-11-01
Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives Grant 9,050,341 - Abidhatla Kali Satya , et al. June 9, 2	2015-06-09
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors App 20150141421 - ADIBHATLA KALI SATYA; Bhujanga rao ; et al.	2015-05-21
6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors Grant 8,921,362 - Adibhatla Kali Satya , et al. December 30, 2	2014-12-30
Polymorphs of erlotinib hydrochloride and method of preparation Grant 8,748,602 - Jyothi Prasad , et al. June 10, 2	2014-06-10
Process for the preparation of lapatinib and it's pharmaceutically acceptable salts Grant 8,664,389 - Jyothi Prasad , et al. March 4, 2	2014-03-04
Novel Polymorphs Of Erlotinib Hydrochloride And Method Of Preparation App 20130131341 - JYOTHI PRASAD; Ramanadham ; et al.	2013-05-23
Polymorphs of erlotinib hydrochloride and method of preparation Grant 8,349,855 - Jyothi Prasad , et al. January 8, 2	2013-01-08
Process For The Preparation Of Lapatinib And Its Pharmaceutically Acceptable Salts App 20120245351 - Jyothi Prasad; Ramanadham ; et al.	2012-09-27
6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders Grant 8,143,250 - Jyothi Prasad , et al. March 27, 2	2012-03-27
Novel Process For The Preparation Of Lapatinib And Its Pharmaceutically Acceptable Salts App 20110263852 - Jyothi Prasad; Ramanadham ; et al.	2011-10-27
Process for the prepartion of erlotinib Grant 7,960,545 - Jyothi Prasad , et al. June 14, 2	2011-06-14
6-7,dialkoxy Quinazoline Derivatives Useful For Treatment Of Cancer Related Disorders App 20110039844 - Jyothi Prasad; Ramanadham ; et al.	2011-02-17
6,7-dialkoxy Quinazoline Derivatives And Methods Of Treating Drug Resistant And Other Tumors App 20110034459 - ADIBHATLA KALI SATYA; Bhujanga rao ; et al.	2011-02-10
Methods Of Treating Drug Resistant And Other Tumors By Administering 6,7-dialkoxy Quinazoline Derivatives App 20110028473 - ADIBHATLA KALI SATYA; Bhujanga rao ; et al.	2011-02-03
Novel Polymorphs Of Erlotinib Hydrochloride And Method Of Preparation App 20100261738 - Jyothi Prasad; Ramanadham ; et al.	2010-10-14
Novel Process For The Prepartion Of Erlotinib App 20090306377 - Jyothi Prasad; Ramanadham ; et al.	2009-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.